Long non-coding RNAs in cancer drug resistance development

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Chemoresistance significantly hinders cancer treatment efficacy.
• Drug resistance involves complex genetic and epigenetic factors.
• Long non-coding RNAs (lncRNAs) regulate crucial cellular processes.

Purpose of the Study:

• To review the fundamental aspects of lncRNAs.
• To elucidate the role of lncRNAs in chemoresistance.
• To explore the therapeutic implications of lncRNAs in cancer.

Main Methods:

• Literature review of lncRNA structure, biogenesis, and function.
• Analysis of studies linking lncRNAs to drug resistance mechanisms.
• Discussion of current research on lncRNA-mediated carcinogenesis and drug sensitivity.

Main Results:

• lncRNAs exhibit diverse regulatory roles in gene expression and epigenetics.
• Specific lncRNAs are implicated in various chemoresistance pathways.
• Understanding lncRNA function is key to overcoming drug resistance.

Conclusions:

• lncRNAs are critical regulators in cancer development and drug response.
• Targeting lncRNAs offers novel therapeutic strategies for overcoming chemoresistance.
• Further research is essential to fully harness lncRNAs for cancer therapy.